Effectiveness of Continuous Glucose Monitoring System Among Cardiac Surgery Patients

Last updated: February 16, 2024
Sponsor: Kangbuk Samsung Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes And Hypertension

Cardiac Disease

Diabetes Prevention

Treatment

Dexcom G6

SMBG or venous/arterial blood glucose

Clinical Study ID

NCT06275971
KBSMC 2022-07-006
  • Ages > 18
  • All Genders

Study Summary

The aim of this study is to assess the level of glycemic control and the incidence of surgery-related complications in cardiac patients post-surgery when Continuous Glucose Monitoring (CGM) is utilized, as compared to traditional methods of arterial/venous blood sampling and Point-of-Care Testing (POCT) for glucose monitoring.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Subjects waiting for Elective Cardiac Surgery (CABG, Cardiac Valve Operation,Congenital heart anomaly surgery, aortic surgery, etc.)
  • Subjects over the age of 18
  • Patients with type 2 diabetes
  • Patients with prediabetes
  1. HbA1c 5.7% or more
  2. fasting blood glucose 100 mg/dL or more
  3. 2 hours 75g-OGTT 140 mg/dL or more

Exclusion

Exclusion Criteria:

  • Emergency surgery patients
  • Patients performing co-operation other than cardiac surgery
  • Patients with type 1 diabetes
  • Total Pancreatectomy patients
  • Patients with high surgical severity (STS score of 8 or more or EURO score of 5 ormore)
  • Patients who do not consent to the study
  • Severe patients who are deemed difficult to continue research during surgery (excludedat the researcher's discretion)
  1. Cases where severe weight gain and severe edema occur after surgery
  2. Cases where the surgery time is significantly longer than average
  3. Cases where cardiopulmonary bypass is used more than once during surgery
  • Others who are deemed unsuitable for research progression at the researcher'sdiscretion

Study Design

Total Participants: 68
Treatment Group(s): 2
Primary Treatment: Dexcom G6
Phase:
Study Start date:
November 24, 2022
Estimated Completion Date:
August 31, 2024

Connect with a study center

  • Kangbuk Samsung Hospital

    Seoul, 03181
    Korea, Republic of

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.